Intensive Medical Treatment after Heart Attack

Phase 4

• Conditions: Heart Failure; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12610000802000
• Lead Sponsor: PAH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-09-27
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Adult patients >60 years old 2 weeks post MI (STEMI, NSTEMI)
LVEF >40% and
LVESVI>30ml/m2 or LVEDVI>75ml/m2 and
BNP >100ng/l

Exclusion Criteria

Known heart failure
Known LVEF<40%
Previous MI (except the primary event)
Severe valvular heart disease
Severe life span limiting medical disease (cancer, Chronic Obstructive Pulmonary Disease (COPD) with FEV1<1.0 l, renal failure serum Creatinine >200mcmol/l)
Systolic Blood Pressure <100mmHg
Lack of consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified